The male god of magic capital

Chapter 149 150 Accounts Quadruple!
Returning to the company, Jiang Ning, the vice president of the human resources department, said: "Boss, people from Daxin Fund came to the company and said that they intend to buy the shares of Fudan Pharmaceutical held by Chengtian Public Fund at the market price."

Luo Cheng: "Reply that they don't sell it."

This Daxin Fund, East Asia Fund seems to have taken a fancy to the stock of Fudan Pharmaceutical. The research team of Chengtian Holdings has been investigating Fudan Pharmaceutical, Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Pien Tze Huang several medical industry giants. Today, the fundamental analysis report has been completed, and Chengtian Private Equity Fund will operate the shares of Fuxing Medical, so naturally it will not sell them to Dah Sing Fund.

"Yes, BOSS" Jiang Ning replied immediately.

Then Luo Cheng opened the stock trend chart of Fudan Pharmaceutical, and it closed at 60 yuan per share on Friday, with a market value of more than 1500 billion. It was not the time for Chengtian Private Equity Fund to build a position, and Luo Cheng planned to wait.

At this time, the phone rang, and it was Huang Hanxing from Dah Sing Bank, "Mr. Luo, do you really think about selling the shares of Fuxing Medicine to our Dah Sing Fund?"

"Recently, Fuxing Pharmaceutical's stock price has dropped from 78 yuan per share to 60 yuan per share. It is normal for it to fall below 50 yuan per share."

Luo Cheng smiled and said, "You don't need to worry about it, Mr. Huang."

Huang Hanxing thought for a while and said: "Before you thought about helping your father pay off the debt, it has been so long, and you have made a lot of money, when will you pay it back?"

"It's only 5 million Hong Kong dollars, and your real worth is nearly 100 billion. Don't tell me, you can't afford 5 million Hong Kong dollars!"

Luo Cheng: "Hehe, it's only 5 million Hong Kong dollars. I said I would pay it back."

"I hope you hurry up." Huang Hanxing reminded.

After finishing the phone call, Luo Cheng continued to read the research report. WuXi AppTec, Mindray Medical, Hengrui Medicine, and Pien Tze Huang all looked at it. In the end, he chose Fuxing Medicine first, but it was not the right time. He waited for the stock price to fall to 50 yuan per share. Enter again.

At present, Chengtian Private Equity Fund has a short position, the A-share account of the Luo Family Foundation is also a short position, and the Hong Kong stock account holds 1250 million shares of Innovent Biotech.

Last Friday, the share price of Innovent Biotech rushed to 60 Hong Kong dollars a share, worth 7.5 million Hong Kong dollars.

Innovent Biologics has made progress in the research and development of different new drugs. At the same time, Innovent Biologics and Eli Lilly and Pharmaceuticals jointly announced the results of a phase Ib clinical study of sintilimab combined with IBI305 in the treatment of advanced hepatocellular carcinoma.

上个星期还公布抗PD-1/PD-L1双特异性抗体IBI318 Ia期临床研究的初步结果，以及公布抗CTLA-4单克隆抗体IBI310 I期临床研究的初步结果。

The cooperation with Roche this time may further accelerate the research and development of Innovent Biologics on the product line. The stock price was reported at HK$60 last Friday, and the stock price hit a record high again, with a total market value of HK$904 billion.

Innovent Biologics and Eli Lilly and Company (LLY.US) will jointly announce six latest clinical research results on Tyvyt (sintilimab injection) at the annual meeting of the European Society for Medical Oncology (ESMO) next week.

In addition, in the 2020 ESMO conference arrangement that has been learned, a total of 6 studies of Tyvyt have been selected, including 2 latest breakthrough abstracts (LBA, mini oral) and 4 electronic posters (e-posters), including 2 ongoing Ongoing Phase III study.The tumor areas covered by the research include: lung cancer, hepatocellular carcinoma, gastric cancer, gynecological tumors, other solid tumors, etc.

At 10 o'clock in the evening, Goldman Sachs Bank, JPMorgan Bank, Murano Securities, Citibank, HSBC, Barclays Bank and other international giant financial institutions once again raised the stock price of Innovent Bio, claiming that the Swiss medical giant Roche Group's $10 billion order About to fall, the stock price of Innovent Biological Company is bullish to 80 Hong Kong dollars per share.

"The stock price should continue to hit new highs next Monday!"

"The market value will exceed [-] billion soon!"

Luo Cheng was very excited, and the opportunity to close the position next week came.

With such a small amount of capital, he can get out of the market at once, and he will close his position when the stock price reaches above HK$80 on Monday.

At the moment, the Jardine Fund under the Jardine Consortium of Xiangjiang.

"Tomorrow, the stock price of Innovent Biologics will skyrocket. Don't let the stock price reach HK$80 a share. We will start liquidating our positions before then," said Henry Cizek, manager of Jardine Fund.

Henry Cizek is the cousin family of the head of the Jardine Group, and is also a member of the Jardine Group. His ancestors also took charge of the Jardine Group.

The Jardine Matheson Group is one of the oldest and well-known enterprise groups in Asia. The business areas of the group include: financial and insurance services, retail department stores, consumer market expansion, engineering and construction, machinery manufacturing, automobile trade, transportation services, real estate and catering etc., all have outstanding leadership positions in the market, with more than 20 employees worldwide.

And Henry Cizek is mainly responsible for the business in the financial field.

This time, Jardine Fund has made a lot of money in the stock of Innovent Biological, but Henry Cizek is a person who pursues perfection, and he wants to maximize his operation.

"Manager, so many international investment banks are bullish on its stock price reaching HK$80 a share, why should we close our positions before the stock price breaks through HK$80?" the beautiful assistant couldn't help asking.

Henry Cizek said with a smile: "In fact, many traders in major international investment banks may start selling stocks above 80 Hong Kong dollars. I just moved ahead of schedule. When the stock market opens tomorrow and the stock price reaches 79 Hong Kong dollars, we will Start to close positions slowly, and keep the stock price below 80 Hong Kong dollars. Many institutions, retail investors, large and small hot money, and institutional traders are all looking forward to the stock price rushing to 80 Hong Kong dollars per share. I just started selling below 80 Hong Kong dollars. Goods, let them take over."

"Manager, you are so wise." The beautiful assistant said admiringly.

Henry Cizek said with a smile: "In fact, I am still optimistic that the stock price of Innovent Biological Company will skyrocket to HK$100, but it will take a long time. In the short term, its amplitude is very large. Stocks will definitely fall sharply, then rise again, fall sharply, rise again, over and over again, I don’t know how long the shock will last, so I will come out first and buy later!”

"I think none of the investors operating Xinda Biological Company is as smart as you!" The beautiful assistant looked at Henry Cizek with affection in her eyes.

And Henry Cizek was also blunt, and directly hugged the beautiful assistant over.

····
The next day, Monday, June 1.

On the eve of the Hong Kong stock market opening.

Switzerland's Roche Medical Group also issued a statement, considering an order of 15 billion to Innovent Biologics.

"Damn it, it must break 80 Hong Kong dollars per share!" Luo Cheng became even more excited.

Soon the stock market will open.

The stock price of Innovent Biotech started to skyrocket!

61.15
62.77
63.45
64.78
···
70.00 position, 70 Hong Kong dollars a share.

Holds 1250 million shares worth HK$8.75 million.

However, many short-term bulls began to close their positions, suppressing the rise in the stock price, and the stock price of Innovent Biotech fluctuated at HK$70 per share. .

"I don't know if the stock price can continue to rise today?"

"Should I withdraw first, without earning the last copper coin."

In fact, with so much good news coming out, it may be the last wave of skyrocketing. After all, the stock price of Innovent Biological Company has been rising continuously, from 20 Hong Kong dollars to the current 70 Hong Kong dollars, which has increased by 3.5 times, and its market value has also exceeded 1000 billion. .

Just when Luo Cheng thought that the skyrocketing price could not continue today, at 11 o'clock, the stock price of Innovent Biological Company started skyrocketing again!

71.45
72.84
73.87
74.78
·
It rushed all the way to the 79.00 position. In just 15 minutes, it skyrocketed by 9 Hong Kong dollars, but the stock price was suppressed again.

"To 80 Hong Kong dollars per share!" Luo Cheng expected it to reach 80 Hong Kong dollars per share, but it happened to be suppressed again.

Then it turned around and started to fall.

At 78 Hong Kong dollars per share, Luo Cheng saw that the situation was not right. It would take a while for the stock price of Innovent Biotech to reach 80 Hong Kong dollars per share. .

Immediately, he chose to close the position, and all 1250 million shares were liquidated, causing the stock price of Innovent Bio to fall all the way.

Although there were a lot of buying orders pouring in during the period, Luo Cheng's 1250 million shares, worth more than 9 million Hong Kong dollars, consumed all the buying orders in the market.

77.45
76.45
75.45
74.00 position before stopping.

Luo Cheng’s average closing position of the 1250 million shares was HK$76 per share, opening position was at HK$20 per share, the profit per share was HK$56, he won HK$7 million, and the assets in his Hong Kong stock account reached HK$9.5 million.

Another 20 minutes passed, and the stock price of Credit Biotech continued to plummet, falling to HK$70 per share.

It hasn't stopped yet, and 10 minutes before the close in the morning, the stock price fell sharply again, all the way down to 66 Hong Kong dollars per share, just falling to the 5 moving average in the daily chart.

"I'll go, I can buy again." Luo Cheng was a little excited.

At the beginning of the afternoon trading, the stock price of Innovent Biotech did not continue to fall, and Luo Cheng started to buy again when he saw this.

The stock price of Innovent Biologics started to soar again in the afternoon trading!

Lots of buying on the market!

67.48
68.47
69.70
70.45
71.45
72.78
At the position of 74.00, Luo Cheng spent 5 million yuan to buy, and the average price of opening a position was 70 Hong Kong dollars per share.

After 15 minutes, the stock price rushed to the 75.00 position, did not stop, and continued to rush!
76.45,

77.74
78.45
At the position of 79.00, Luo Cheng saw this and immediately closed his position. He hadn’t rushed to 80 Hong Kong dollars per share before, and it was the same this time, so he didn’t hesitate to close his position at all.

Luo Cheng directly checked it out, causing the stock price to turn around and plummet.

78.12
77.55
76.45
76.11
75.00, the average closing position is 77.00, the average opening position is 70.00, the profit is 10%, and 5000 million Hong Kong dollars has been won.

This small short-term operation made a profit of 5000 million Hong Kong dollars, which is very good, and Luo Cheng is quite satisfied.

The Hong Kong stock account of the Luo Family Foundation has 10 billion Hong Kong dollars!
The account has quadrupled!
This operation on Innovent Biological Company was very successful, from 2.5 million Hong Kong dollars to 10 billion Hong Kong dollars.

Especially in the end, I did ultra-short-term and won 5000 million Hong Kong dollars. The operation is quite perfect.

And Henry Cizek of the Jardine Fund is a little furious!

"FUCK!"

'Who the hell is walking in and out in front of me! '

He didn't expect that there were still people in the market who acted ahead of time, which made his operation very difficult today.

(End of this chapter)